Literature DB >> 9552453

Glass fragility and the stability of pharmaceutical preparations--excipient selection.

R H Hatley1.   

Abstract

The objectives of this study were, first, to calculate the zero mobility temperatures, T0, of trehalose and sucrose by the Pikal method from the width of the glass transition and compare these to the literature, obtained by enthalpy relaxation measurement, and second, to compare the T0 values and physicochemical properties of trehalose to those of sucrose in terms of potential to stabilize labile actives in the glassy state. Differential scanning calorimetry and coulometric Karl-Fischer analysis were used. The glass transition temperatures, Tg, for the two carbohydrates at circa 0.7% moisture were 101 degrees C and 64 degrees C for trehalose and sucrose, respectively. Anhydrous amorphous trehalose had a Tg of 116 degrees C. The T0 values were found to be 44 and 3.5 degrees C for trehalose and sucrose, respectively. The Tg-T0 value for sucrose was compared, and found to be in good agreement with that found by enthalpy relaxation measurements. Trehalose was found to be resistant to crystallization above the glass temperature. The study supports the validity of the calculation method proposed by Pikal for T0. It has been proposed in the literature that T0 is a better measure of stability than Tg. Trehalose has a significantly higher T0 than sucrose and thus would work more effectively in stabilizing a labile active.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9552453     DOI: 10.3109/10837459709031445

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  7 in total

1.  Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids.

Authors:  David Lechuga-Ballesteros; Aziz Bakri; Danforth P Miller
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

2.  Comparative investigation by two analytical approaches of enthalpy relaxation for glassy glucose, sucrose, maltose, and trehalose.

Authors:  Kiyoshi Kawai; Tomoaki Hagiwara; Rikuo Takai; Toru Suzuki
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

3.  Estimating the critical molecular mobility temperature (T(K)) of amorphous pharmaceuticals.

Authors:  B C Hancock; K Christensen; S L Shamblin
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

4.  Physicochemical properties of amorphous roxithromycin prepared by quench cooling of the melt or desolvation of a chloroform solvate.

Authors:  Marique Aucamp; Wilna Liebenberg; Schalk J Strydom; Elsa C van Tonder; Melgardt M de Villiers
Journal:  AAPS PharmSciTech       Date:  2012-03-06       Impact factor: 3.246

5.  Structural and dynamic properties of crystalline and amorphous phases in raffinose-water mixtures.

Authors:  K Kajiwara; F Franks; P Echlin; A L Greer
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

6.  Effect of sucrose/raffinose mass ratios on the stability of co-lyophilized protein during storage above the Tg.

Authors:  P Davidson; W Q Sun
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

7.  Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms.

Authors:  Bei Chen; Raquel Bautista; Kwok Yu; Gerardo A Zapata; Michael G Mulkerrin; Steven M Chamow
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.